These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1466275)

  • 1. Characterization of cell binding and thrombin inhibitory regions on kininogens' heavy chain.
    Jiang YP; Schmaier AH
    Agents Actions Suppl; 1992; 38 ( Pt 1)():233-40. PubMed ID: 1466275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets.
    Jiang YP; Muller-Esterl W; Schmaier AH
    J Biol Chem; 1992 Feb; 267(6):3712-7. PubMed ID: 1740422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation.
    Meloni FJ; Schmaier AH
    J Biol Chem; 1991 Apr; 266(11):6786-94. PubMed ID: 2016293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
    Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
    Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
    Meloni FJ; Gustafson EJ; Schmaier AH
    Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 of domain 3 in the heavy chain of high molecular weight kininogen.
    Kunapuli SP; Bradford HN; Jameson BA; DeLa Cadena RA; Rick L; Wassell RP; Colman RW
    J Biol Chem; 1996 May; 271(19):11228-35. PubMed ID: 8626672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
    Hasan AA; Cines DB; Zhang J; Schmaier AH
    J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254.
    DeLa Cadena RA; Kunapuli SP; Walz DA; Colman RW
    Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High molecular weight kininogen binds to unstimulated platelets.
    Gustafson EJ; Schutsky D; Knight LC; Schmaier AH
    J Clin Invest; 1986 Jul; 78(1):310-8. PubMed ID: 3722381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPACK-thrombin is a noncompetitive inhibitor of alpha-thrombin binding to human platelets.
    Schmaier AH; Meloni FJ; Nawarawong W; Jiang YP
    Thromb Res; 1992 Sep; 67(5):479-89. PubMed ID: 1448784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain.
    Bradford HN; Jameson BA; Adam AA; Wassell RP; Colman RW
    J Biol Chem; 1993 Dec; 268(35):26546-51. PubMed ID: 8253784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.
    Gustafson EJ; Lukasiewicz H; Wachtfogel YT; Norton KJ; Schmaier AH; Niewiarowski S; Colman RW
    J Cell Biol; 1989 Jul; 109(1):377-87. PubMed ID: 2526132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an endothelial cell binding site on kininogen domain D3.
    Herwald H; Hasan AA; Godovac-Zimmermann J; Schmaier AH; Müller-Esterl W
    J Biol Chem; 1995 Jun; 270(24):14634-42. PubMed ID: 7540175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of inhibition of platelet calpain II by human kininogens.
    Bradford HN; Schmaier AH; Colman RW
    Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains.
    Reddigari SR; Kuna P; Miragliotta G; Shibayama Y; Nishikawa K; Kaplan AP
    Blood; 1993 Mar; 81(5):1306-11. PubMed ID: 8443392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory and antiadhesive properties of human kininogens.
    Colman RW
    Immunopharmacology; 1996 May; 32(1-3):9-18. PubMed ID: 8796259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
    Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
    Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thrombin high-affinity binding site on platelets is a negative regulator of thrombin-induced platelet activation. Structure-function studies using two mutant thrombins, Quick I and Quick II.
    Leong L; Henriksen RA; Kermode JC; Rittenhouse SE; Tracy PB
    Biochemistry; 1992 Mar; 31(9):2567-76. PubMed ID: 1547239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.